🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

IonQ shares target cut by Needham but retains Buy rating

EditorTanya Mishra
Published 08/08/2024, 09:30 AM
IONQ
-

Needham has maintained a Buy rating on IonQ, Inc. (NYSE: IONQ) but reduced the price target to $13 from the previous $18.

The adjustment follows IonQ's announcement of better-than-expected revenue for the second quarter of 2024 and an increase in its full-year revenue forecast.

The company reported substantial progress on its percentage of completion contracts, which contributed to higher revenue in the second quarter and an optimistic outlook for the remainder of the fiscal year.

IonQ also announced advancements in quantum computing technology, including partial error correction for Clifford gates, which are known for their high noise levels. Management believes this development brings the company closer to achieving a commercial advantage in the market.

Additionally, IonQ has secured a significant contract from ARLIS worth $40 million. The contract will be executed in multiple phases, with an immediate payment of $5.7 million this year. The company anticipates an additional $12 million in bookings before the end of 2024, with the remaining amount expected to be booked in 2025.

Moreover, IonQ has revealed a prototype Barium system that has achieved 99.9% fidelity in two-qubit gates, marking a notable milestone in quantum computing performance.

IonQ has been making significant strides in the quantum computing sector. The company recently secured a $5.7 million contract from the Applied Research Laboratory for Intelligence and Security (ARLIS) to design a networked quantum computing system for the U.S. Department of Defense and Intelligence Community.

This project is part of a broader federal initiative to establish leadership in quantum technologies. The company has also announced the promotion of Dr. Dean Kassmann to Senior Vice President of its newly established Engineering and Technology division.

Dr. Kassmann's leadership will be instrumental in fostering an environment conducive to research and innovation, which is crucial for IonQ's advancement in the quantum computing field.

In terms of financial performance, IonQ reported $7.6 million in revenue for the first quarter of 2024, surpassing its revenue expectations. Despite a net loss of $39.6 million for the quarter, the company's strong bookings pipeline has led to an upward revision of its full-year bookings guidance to a range of $75 million to $95 million. IonQ maintains a robust cash position with over $434 million in reserves.

InvestingPro Insights

Following Needham's maintained Buy rating on IonQ, Inc. (NYSE: IONQ), with a revised price target, InvestingPro data provides additional context to the company's financial landscape. IonQ's market capitalization stands at approximately $1.44 billion, signaling investor confidence in their market position despite recent volatility. Notably, the company holds a striking revenue growth rate of 90.62% for the last twelve months as of Q2 2024, underscoring its rapid expansion in the quantum computing field. Nevertheless, IonQ's high operating income margin deficit of -635.98% indicates substantial investments in research and development, which are intrinsic to the nature of cutting-edge technology companies.

InvestingPro Tips highlight that analysts have revised earnings downwards for the upcoming period, reflecting caution in the face of aggressive growth. The company's stock has experienced significant price fluctuations, with a 55.64% decline over the past year, which may present a buying opportunity for long-term investors who believe in the potential of quantum computing. IonQ's ability to maintain liquid assets that exceed short-term obligations, paired with the absence of dividend payouts, suggests a focus on reinvesting capital to fuel growth. For investors seeking a more in-depth analysis, there are 10 additional InvestingPro Tips available for IonQ, providing a comprehensive understanding of the company's financial health and prospects at https://www.investing.com/pro/IONQ.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.